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A rare novel mutation in TECTA causes autosomal
dominant nonsyndromic hearing loss in a
Mongolian family
Haihua Bai1*†, Xukui Yang2†, Temuribagen1†, Guilan1, Suyalatu1, Narisu Narisu3, Huiguang Wu1, Yujie Chen1,
Yangjian Liu4 and Qizhu Wu2*

Abstract
Background: The genetic basis of autosomal dominant nonsyndromic hearing loss is complex. Genetic factors are
responsible for approximately 50% of cases with congenital hearing loss. However, no previous studies have
documented the clinical phenotype and genetic basis of autosomal dominant nonsyndromic hearing loss in
Mongolians.
Methods: In this study, we performed exon capture sequencing of a Mongolian family with hereditary hearing loss
and identified a novel mutation in TECTA gene, which encodes α -tectorin, a major component of the inner ear
extracellular matrix that contacts the specialized sensory hair cells.
Results: The novel G → T missense mutation at nucleotide 6016 results in a substitution of amino acid aspartate at
2006 with tyrosine (Asp2006Tyr) in a highly conserved zona pellucida (ZP) domain of α-tectorin. The mutation is not
found in control subjects from the same family with normal hearing and a genotype-phenotype correlation is
observed.
Conclusion: A novel missense mutation c.6016 G > T (p.Asp2006Tyr) of TECTA gene is a characteristic TECTA-related
mutation which causes autosomal dominant nonsyndromic hearing loss. Our result indicated that mutation in
TECTA gene is responsible for the hearing loss in this Mongolian family.
Keywords: TECTA gene, Mongolian family, Autosomal dominant nonsyndromic hearing loss

Background
Hearing loss is one of the most common sensory disorders in humans. Genetic factors are responsible for approximately 50% of cases with congenital hearing loss
[1,2]. While 30% of hereditary hearing loss are syndromic associated with specific signs and medical problems, the other 70% are nonsyndromic [3]. The heredity
of nonsyndromic hearing loss has recessive and dominant modes of inheritance. It is estimated that 80% of
genetic forms of hearing loss is autosomal recessive and
the remaining 20% is autosomal dominant [2]. Autosomal dominant nonsyndromic hearing loss (ADNSHL)
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is represented by heterogeneity of genetic and clinical
features. To date, about 60 loci associated with ADNSHL
have been mapped but only 24 genes have been identified [4].
As one of causative genes of ADNSHL, TECTA mutations have been identified in various types of hearing
loss, age of onset, progression and frequency involvement in various populations [5-13]. This gene encodes
α-tectorin, the major noncollagenous component of tectorial membrane which contacts the outer cochlear hair
cells and has an important role in intracochlear sound
transmission [14]. The α-tectorin is composed of three
distinct modules: the entactin G1 domain, the zonadhesin (ZA) domain and the zona pellucida (ZP) domain
[14]. Missense and nonsense mutations in the entactin
G1 domain and ZP domain are associated with hearing
impairment at mid-frequency, whereas mutations in the
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ZA domain primarily affect hearing at the high frequencies [13,15]. Phenotypes of hearing loss associated with
TECTA can range from mild to severe and have pre or
postlingual onset [13].
In this study, we examined the genetic basis of ADSHNL
in a Mongolian family with hereditary hearing loss by
exon-capture sequencing of known genes associated with
hearing loss and identified a novel mutation in TECTA
gene. This novel mutation causes the aspartate to tyrosine
substitution (Asp2006Tyr) in the highly conserved ZP domain of α-tectorin. We further studied the genotypephenotype correlation of mutation in TECTA gene with
control subjects from the same family with normal hearing
and confirmed that mutation in TECTA gene is responsible for the hearing loss in this Mongolian family.

Page 2 of 8

Patients of a Mongolian family suffered severe hearing
impairment were diagnosed in the Affiliated Hospital of
Inner Mongolia University for the Nationalities. Clinical
examination showed that none of these patients has any
other associated neurological signs, visual dysfunction or
diabetes mellitus. Nineteen members of this Mongolian
family participated in the study, of which fourteen
showed clinical symptoms of hearing impairment. The
study protocol was approved by the Committee on Clinical Investigation at the Inner Mongolia University for the
Nationalities University. Informed written consent was
obtained from all study participants and the study was
in accordance with regulations by the Inner Mongolia
University for the Nationalities University.

Covaris (Covaris S2, Massachusetts, USA) into segments
ranging from 200 bp to 300 bp. These DNA fragments
were purified and quantified, and then adapters were ligated to both ends. After amplified by ligation-mediated
PCR (LM PCR), adapter-DNA fragments were hybridized to the capture-array of BGI (BGI, Shenzhen, China)
to capture all target genes for 72h. After washing off
non-hybridized fragments, captured library which contains the targeted exon sequences of 54 known genes associated with hearing loss was loaded on the Hiseq2000
platform (Illumina, San Diego, USA). Raw image files
were processed by Illumina base calling Software 1.7 for
base calling with default parameters and the sequences
were generated as 90bp paired-end reads.
After removing adapter sequences and low quality sequence reads from the raw data, the remaining clean
reads were mapped and aligned to the human reference
genome (NCBI build 37.1/hg19) using Burrows Wheeler
Aligner (BWA). SNPs and indels (insertion and deletion)
were called by SOAPsnp and GATK (http://www.broadinstitute.org/gsa/wiki/index.php/, The Genome Analysis
Toolkit), respectively. All variants of the samples were filtered by databases including dbSNP137 (http://hgdownload.
cse.ucsc.edu/goldenPath/hg19/database/snp137.txt.gz), HapMap project (ftp://ftp.ncbi.nlm.nih.gov/hapmap), 1000
Genome Project (ftp://ftp.1000genomes.ebi.ac.uk/vol1/
ftp), and an in-house database of BGI. After filtering,
variants were further analyzed by SIFT and PolyPhen
to predict the effect of mutation on the function of
encoding proteins. Only variants that had significant
impact on the function of the target protein were further analyzed.

Audiometric evaluation

Sanger sequencing

Hearing impairment was evaluated by pure tone audiometry (PTA) in a sound-controlled room at frequencies
ranging from 500 to 8000 Hz, according to standard protocols. The severity of hearing loss was defined as follows
based on the mean PTA using the thresholds measured
at 500, 1000, 2000, and 3000 Hz: normal hearing, below
20 dB; mild hearing impairment, 21 - 40 dB; moderate
hearing impairment, 41 - 70 dB; severe hearing impairment, 71 – 95 dB; and profound hearing impairment, > 95
dB [16]. The range of hearing loss was described as follows depending on the PTA: low frequency, 125 - 1000
Hz; mid-frequency, 1000 - 4000 Hz; and high frequency,
4000 - 8000 Hz.

Candidate variants observed via target exon capture sequencing were screened in other family members who
participated the study using conventional capillary sequencing. Briefly, DNA fragments containing variants
were PCR amplified from 10-40 ng of genomic DNA
using a touch down protocol with primers listed in
Table 1. PCR products were visualized on agarose gels,
purified with Sephadex columns in accordance with the
manufacturers’ protocols. Sequence analysis was performed with the Big Dye Terminator Cycle Sequencing
Kit and the ABI PRISM 3730 DNA Analyzer (Applied

Target exon capture sequencing

Loci

Primer sequence (5'-3')

Size (bp)

Approximately 4 mL of peripheral blood were collected
from each study participant and genomic DNA was extracted using the QIAamp DNA Blood Mini Kit (Qiagen,
Hilden, Germany). The qualified genomic DNA sample
of the affected subject III21 was randomly fragmented by

TECTA-F

GGTCACTTTCAAATGTAAAGG

443

TECTA-R

CACTGTCCCATCAAAGATGAC

Methods
Subjects

Table 1 Primers of TECTA and SLC26A4 gene

SLC26A4-F

GCTGATATCATGGTTTTTCATG

SLC26A4-R

ACACAAATAGGACTATTGAAGG

581
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Biosystems). Sequence traces were analyzed using the
Sequencher 4.7 program (Gene Codes Corporation).

Results
ADSHNL diagnosis and clinical study

We ascertained a Mongolian family with autosomal
dominant nonsyndromic hearing loss. The pedigree
comprises four generations with 19 affected family members (9 males and 10 females), 14 of whom are willing to
participate in this study (Figure 1). There was no evidence of any other cause of hearing impairment, except
for one patient who had undergone stapes replacing surgery for unilateral otosclerosis. This patient was included
in this study but only audiometric data from her other
non-surgical ear were used. The first symptoms of hearing impairment were self-reported at ages ranging from
1 to 69 years. No vestibular symptoms were reported.
Otoscopy was normal in all subjects except the abovementioned patient. Pure tone audiograms (PTA) were
symmetric and often displayed a so-called cookie-bite
shape, which indicates that the survey frequencies are
predominantly affected (Figure 2). The highest threshold
was most often found at 1000 Hz and followed by 2000
Hz. The PTA was usually within the range of 40–120 dB
and apparently independent of age. By contrast, the PTA
from control subjects with normal hearing was in the
range of 0–40 dB (Figure 2).
Identification of candidate mutation

To understand the genetic basis underlying the hearing
loss in this Mongolian family, we took the candidate
gene approach to screen 54 known hearing loss associated genes with exon capture followed by deep sequencing of the DNA sample from the patient III21. We then
analyzed the SNPs and indels mutation from sequencing reads. The bioinformatic analysis identified four
missense variants (p.Arg371Gly, p.Val932Ala, p.Ser1724Asn and p.Asp2006Tyr) and four synonymous variants
(p.Ala495Ala, p.Ile752Ile, p.Tyr935Tyr, p.Ser1878Ser)
in coding region of TECTA (Table 2), which encodes
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α-tectorin, a major component of the inner ear extracellular matrix that contacts the specialized sensory hair
cells. One missense mutation (p.Cys282Gly) in SLC26A4
was also called in the aforementioned analyzed strategy.
No other mutation was identified in the rest of known
hearing loss associated genes, including ACTG1, CCDC50,
COCH, COL11A2, DFNA5, DIAPH1, and EYA4 et al. for
this patient sample.
The sequencing coverage of every exon of TECTA was
up to 99%, and the depth of each exon was close to the
average median-depth across 23 exons, indicating sequencing in our study is deep enough for identifying all
possible variants (Figure 3B). This suggests the abovementioned variants are the possible causative mutations
impairing the hearing of this Mongolian family. To narrow
down the candidate variants of TECTA, we then filtered
these variants with four databases (dbSNP, HapMap, 1000
project and in-house database of BGI) with a minor allele
frequency (MAF) of 0.005. Only p.Asp2006Tyr was left
after filtering, suggesting a novel variant in TECTA.

Genotype-phenotype correlation study

The TECTA gene is known as a causative gene for
DFNA8/DFNA12 and DFNB21 hearing loss in humans,
and SLC26A4 is related to autosomal recessive hearing
loss. The missense mutations p.Asp2006Tyr of αtectorin and p.Cys282Gly of SLC26A4 are heterozygous,
which fits the autosomal dominant inheritance model.
These two mutations have not been reported previously
based on the public databases. The p.Asp2006Tyr of
α-tectorin and p.Cys282Gly of SLC26A4 were predicted
to be pathogenic mutations by SIFT and PolyPhen. Thus,
p.Asp2006Tyr of α-tectorin and p.Cys282Gly of SLC26A4
were considered as candidate causative mutations of
hearing loss in the studied Mongolian family. Therefore, we further screened these mutations in other affected subjects using Sanger sequencing for a genotype
phenotype correlation analysis with primers listed in
Table 1.

Figure 1 Pedigree of the Mongolian family. Black and white symbols indicate the affected and the unaffected subjects, respectively.
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A

B

II-5 (64 yrs old)

II-7 (60 yrs old)

II-8 (55 yrs old)

III-3 (53 yrs old)

III-21 (34 yrs old)

IV-14 (28 yrs old)

II-3 (69 yrs old)

III-7 (51 yrs old)

III-11 (43 yrs old)

Figure 2 Pure tone audiometry recording of representative members in the Mongolian family. A. audiograms of six different patients in
three generations (only audiograms of left ear is shown). X: frenquency; Y: intensity (dB). B. audiograms of the left ear of three different control
subjects in two generations. The age of each subject at the time of tested was indicated.

Sequencing of three patients and three control subjects
in the family showed that c.844 T > G (p.Cys282Gly)
in SLC26A4 is also present in controls, ruling out the
association of p.Cys282Gly in SLC26A4 with hearing
loss in the studied Mongolian family. We then confirmed the presence of the novel missense mutations
c.6016 G > T (p.Asp2006Tyr) of the TECTA gene in

exon 20 of the rest of all 13 participated subjects
with hereditary hearing loss (Figure 4B). The affected
members in this family (II-2, III-3, III-5, and III-10)
were heterozygous for the mutation, but not detected
in the II-1. This is consistent with a complete segregation of the variant allele with the phenotype status
in this family (Figures 1 and 4B). This mutation is
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Table 2 Mutations identified by exon-capture sequencing
Variants

Rs_ID

MAF-dbSNP

MAF-HapMap

MAF-1K project

MAF-in-house

p.Arg371Gly

rs612969

0.5

0.394

0.4432

0.3892

p.Ala495Ala

rs536069

0.629

0.533

0.6007

0.4627

p.Ile752Ile

rs10502247

0.449

0.474

0.402

0.4988

p.Val932Ala

rs520805

-

0.387

0.3526

0.3843

p.Tyr935Tyr

rs586473

0.588

0.504

0.5696

0.4663

p.Ser1724Asn

rs526433

-

0.993

0.9936

0.9964

p.Ser1878Ser

rs2155369

-

0.314

0.2244

0.4181

p.Asp2006Tyr

novel

-

-

0

0

located in the ZP domain of α-tectorin which is
highly conserved across species (Figure 4C). We further sequenced DNAs of all the normal control subjects of the family, plus screened additional 201
healthy individuals from a random Mongolian population sample that we have deep sequencing data. We
did not find the presence of the above-mentioned p.
Asp2006Tyr mutation in the TECTA gene (data not
shown), demonstrating the genotype-phenotype correlation of the mutation in TECTA gene with the
hearing loss in the Mongolian family.

Discussion
TECTA encodes α-tectorin, the major component of
extracellular matrix contacting cochlear hair cells and
transmitting sounds [14]. Mutations in α-tectorin have
been detected in ADNSHL in various populations across
different ages of onset and progressions [5-13], accounting for ~4% of all cases [13]. Interestingly, previous
studies showed that mutations affecting three different
domains (entactin G1 domain, ZA domain, and ZP)
present clinically different phenotypes. Missense mutations on the ZA domain are normally affecting hearing
at the high frequencies, whereas mutations on entactin
G1 domain and ZP domain are linked to mid-frequency
hearing impairment [13,15]. ADNSHL patients with mutations in α-tectorin display various severity and onset of
hearing loss [13].
In this study, we did exon-capture followed by nextgeneration sequencing to screen 54 known hearing-loss
associated genes for mutations in a Mongolian family
with hereditary hearing loss. We identified four missense variants (p.Arg371Gly, p.Val932Ala, p.Ser1724Asn
and p.Asp2006Tyr) and four synonymous variants
(p.Ala495Ala, p.Ile752Ile, p.Tyr935Tyr, p.Ser1878Ser)
in coding regions of TECTA. Among these, a novel
variant, p.Asp2006Tyr was found to be implicated as
the pathogenic missense mutation causing hearing loss.
All TECTA mutations described to date have shown
significant genotype-phenotype correlation with hearing
loss [5-13]. In our study, the novel heterozygous mutation

p.Asp2006Tyr on TECTA is only present in affected members of the family and is not found in any of the control
subjects in the family plus a fairly large population sample
of the same ethic group. Consistent to previous reports
that mutations on the ZP domains are associated with
mid-frequency hearing loss, the hearing of affected subjects was predominantly affected at the frequency between
1000 Hz and 2000 Hz. The clinical phenotype of hearing
loss in this family displays early onset (as early as 1 year
old). However, no correlation between age and severity of
hearing impairment has been observed.
Several recently developed mouse lines with human
mutations on Tecta provide extremely useful information for understanding the mechanism of hearing loss
in the affected families [17-19]. Mice with missense
mutation in the ZP domain of Tecta (TectaY1870C/+,
TectaL1820F,G18724D/+ and TectaC1837G/+) display hearing
loss in mild-frequency range, phenocopying the clinical
observation with affected patients [17,19]. By contrast, the
hearing impairment in mice carrying missense mutation in the ZA domain of Tecta (TectaC1509G/+ and
TectaC1619S/+) is more subtle and slightly different from
what had been reported in patients [18,19]. While the
TectaC1509G/+ mouse had increased reverse transduction
[18], the TectaC1619S/+ mouse was surprisingly found to
have a stable rather than progressive deterioration hearing
phenotype [19]. The authors suggested the genetic traits
of the mouse lines could be a possible explanation for the
different deafness phenotype in mouse and human caused
by the same mutation. Likewise, the age-independency of
hearing loss in the large Mongolian family under this
study is probably dues to the slight difference in their individual genetic background. A knockin mouse line with
TectaD1619Y/+ will be very useful to investigate how the
point mutation identified in current study affects the onset
of deafness under various mouse genetic backgrounds.
This novel variation p.Asp2006Tyr in the ZP domain
was a substitution of aspartate with a hydrophilic side
chain to tyrosine with a hydrophilic-neutral chain. Previously, various mutations in the ZP domain (C1837G,
R2021H, and Y1870C) of TECTA had been shown
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Figure 3 Genomic DNA extraction and TECTA exon-capture sequencing report. A. Agarose gel examination of genomic DNA quality. 1:I2; 2:
II3; 3:III15; 4: III7;5: IV6; 6: II2;7: II7;8: II5;9: II8;10: III3; 11: III10;12: III21;13: III26;14: III28;15: IV4;16: IV14; 17:IV18. B. TECTA exon-capture sequencing report.
Mean depth(X): the sequencing depth of each exon. Median depth(X): This number of depth is the median depth when depth of all sites was in
an ascending sort. Coverage (%): Divide the total length of the target regions by bases generated by sequencing.

within the cytoplasm, suggesting the defect for the mutants to be secreted outside of the cell properly [20]. It
seems likely that the p.Asp2006Tyr mutation in the
ZP domain from this study might also cause similar
defects in the secretion of α -tectorin. However, it is
of note that the secretion defect of mutations in the
ZP domain was drawn from truncated constructs of
TECTA without N-terminal secretion peptide signal.
Further cellular studies with full-length constructs are

necessary to elucidate the exact mechanism of αtectorin’s role in ADNSHL.

Conclusion
This study documents a novel missense mutations c.6016
G > T (p.Asp2006Tyr) of the TECTA gene that causes
autosomal dominant nonsyndromic hearing loss in a
Mongolian family. This expands the mutation spectrum of
TECTA gene in nonsyndromic hearing loss. Our study
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A

B

C

Figure 4 Sequencing analysis of novel missense mutation in exon 20 of TECTA. A. Agarose gel analysis of PCR product TECTA exon 20. 1:I2;
2:II3; 3:III15; 4: III7;5: IV6; 6: II2;7: II7;8: II5;9: II8;10: III3; 11: III10;12: III21;13: III26;14: III28;15: IV4;16: IV14; 17:IV18. B. Representative Sanger sequencing
trace showing heterozygous missense mutation at G6016T (arrow) from patients and control subjects. C. Multi-species alignment of amino acids
encoded by exon 20 of TECTA across different vertebrates. The conserved aspartate residue is highlighted in red.
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also exemplifies the application of deep sequencing in
identifying disease causative mutations from a pedigree.
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